Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00729976Phase 4Unknown
Phase 4, randomised, open-label trial of ibuprofen in fever (2 arms), sponsored by Shamir Medical Center. Primary endpoint: Maximal change in temperature during the 4-hour period after enrollment. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00729976.